Research Opportunities

Fellows are expected to complete a minimum of one research project, leading to abstract publication, or develop a full IRB approved protocol during their training. Research efforts will vary a great deal depending on the fellow from a very few months up to 18 months dedicated time, depending on interest and funding.

Fellows will choose a mentor early in their first year and learn research methodology in practical ways by developing and pursuing a project of interest. Large patient data banks are available to review questions of interest. Our program is linked with a multi-institutional national research network (ACORN) which provides the opportunity to design investigator initiated clinical trials. The University of Tennessee and St Jude's research hospital provide pathways toward bench and translational research as well.

Cancer Research Center

Below are listed some of the abstracts and publications our most recent fellows have completed during their time in the program:

Publications

Rafael Arteta-Bulos
Tissue Acquisition for Anaplastic Lymphoma Kinase (ALK) Gene Mutation Profiling Studies in Upper Aero digestive Tract Malignancies and Breast Cancer. University of Tennessee Cancer Institute & St. Jude's Children Research Hospital. R. Osarogiagbon, R. Arteta-Bulos, P. Naini. [Poster/ Abstract at ASCO 2013]

Phase Ib Study to evaluate safety, tolerability and efficacy R1507 a monoclonal antibody to IGF-1R in combination with multiple standard chemotherapy regimens in patients with advanced solid malignancies.Mahadevan D, Sutton G, Arteta-Bulos R, Miller P, Swart R, Walker M, Munster P, Dees C, Haluska P, Maitland M, Marshall J, Hamid O and Kurzrock R [ASCO Abstract 2013]

Prognostic significance of circulating tumor cell (CTC) levels at various times during first- and second-line chemotherapy for metastatic breast cancer (MBC). Rafael Arteta-Bulos, Paul J. E. Miller, Rebecca S. Overbury, Alison Schwartzberg, Mark S. Walker, Lee Steven Schwartzberg; University of Tennessee Health Science Center, Memphis, TN; ACORN Research, LLC, Memphis, TN; ACORN Research, LLC and The West Clinic, Memphis, TN [Abstract-ASCO 2012]

Winner - Dr. James Dale Research Day Presenting Fellow Award 2013. The University of Tennessee Health Science Center. "Prognostic significance of circulating tumor cell (CTC) levels at various times during first- and second-line chemotherapy for metastatic breast cancer" [Oral Presentation February 2013]

Noman Haider
Epidemiology and outcomes of about 600 AML patients treated at Casablanca Ibn Rochd Hospital, Morocco under the AML MA 2003 Protocol. under the direction of Dr. Raul Ribeiro, International Outreach program, St. Jude Research Hospital (SJCRH), Memphis, TN

Prospective Evaluation of Elderly Lung Cancer Patients with a Pre- Surgical Vulnerability Survey - [IRB Protocol submitted].

Mansoor Haq
QI Project -Improving referral and transfer of information from in-patient setting to out-patient clinic at the Regional Medical Center

Grant Project - "Toxicity and outcomes in African-American and Caucasian patients with adjuvant/neo-adjuvant chemotherapy for breast cancer." Dr. Lee Schwartzberg, M.D., Dr. Pranitha Naini, M.D., Dr. Jessica Snider, D.O., and Dr. Mansoor Ul Haq, M.D.

Bojia Li
Research Grant "Sipuleucel in men with metastatic castration resistant prostate cancer" Dr. Brad Somer, M.D., and Dr. Bojia Li, M.D.

Pranitha Naini
Research Grant "Toxicity and outcomes in African-American and Caucasian patients with adjuvant/neo-adjuvant chemotherapy for breast cancer." Dr. Lee Schwartzberg, M.D., Dr. Pranitha Naini, M.D., Dr. Jessica Snider, D.O., and Dr. Mansoor Ul Haq, M.D.

Naini P, Weir AB, Lewis J, Rajanna K. Evaluation of a method to improve the consent process: improved data retention with stagnant comprehension. Journal of Cancer Education. 28 (1):38-42, March 2013

Sachdev JC, Naini P, Arteta-Bulos R, Hout DR, Hirsch FR, Osarogiagbon RU, Morris S. Anaplastic lymphoma kinase (ALK): A potential oncogenic driver in triple-negative breast cancer? ASCO 13th Annual Meeting, Chicago, May 31st 2013. [Poster presentation]

Vontela NR, Naini P, Martin M, Sherman M. CLAG - A novel therapeutic option for secondary Myelofibrosis. [Poster presentation]

Obiageli Ogbata
QI project - Drug Utilization evaluation of erythropoietin pre and post APPRISE

Research Grant "Identification of micro-RNA (miRllA) genomic profiling and its potential use in predicting outcome and response to chemotherapy in muscle invasive transitional cell bladder cancer." Dr. Daruka Mahadevan, M.D., and Obiageli Ogbata, MD

Real World Symptom Burden and Early Treatment Discontinuation in 1st Line Metastatic Breast Cancer Authors: Mark S. Walker, PhD1, Anthony S. Masaquel, PhD, MPH2, Jiandong Kerr, MS1, Deepa Lalla, PhD2 Daejin Abidoye, MD, MPH,2 Obiageli Ogbata, MD,3 Lee S. Schwartzberg, MD3, Poster Presentation: ASCO 2013

Manjari Pandey
Research Grant "Molecular Hallmarks of Transformed Follicular Lymphoma" Dr. Daruka Mahadevan, M.D., and Dr. Manjari Pandey, M.D.

Jashmin Patel
Research Grant "Hydrocytolytic Peritoneal Lavage in Ovarian Cancer" Joseph Santoso, M.D., Lawrence Pfeffer, PhD, and Jashmin K. Patel, M.D.

Jessica Snider
Research Grant "Toxicity and outcomes in African-American and Caucasian patients with adjuvant/neo-adjuvant chemotherapy for breast cancer." Dr. Lee Schwartzberg, M.D., Dr. Pranitha Naini, M.D., Dr. Jessica Snider, D.O., and Dr. Mansoor Ul Haq, M.D.

Gregg Sutton
Phase Ib Study to evaluate safety, tolerability and efficacy R1507 a monoclonal antibody to IGF- 1R in combination with multiple standard chemotherapy regimens in patients with advanced solid malignancies. Mahadevan D, Sutton G, Arteta-Bulos R, Miller P, Swart R, Walker M, Munster P, Dees C, Haluska P, Maitland M, Marshall J, Hamid O and Kurzrock R [ASCO Abstract 2013]


  • Graduation 2013 Graduation 2013
  • First Year Fellows 1st Year Fellows
  • Drs. Ogbeide and Lawson review clinic notes Drs. Ogbeide and Lawson review clinic notes
  • Dr. Osa Ogbeide Dr. Osa Ogbeide
  • Drs. Snider and Ogbata Drs. Snider and Ogbata
  • 2nd Year Fellows 3rd Year Fellows
  • Dr. Bojia Li presents at Journal Club Dr. Bojia Li presents at Journal Club
  • 1st Year Fellows 2nd Year Fellows
  • Drs. Haq and Pandey discuss patient care Drs. Haq and Pandey discuss patient care
  • Dr. Carolyn Chesney leads the Hematology Symposium Dr. Chesney leads the Hematology Symposium

Contact Us

Division of Hematology & Oncology

Site contact:
Janet Herriman
Residency Coordinator
100 Humphreys Blvd.
Memphis TN 38120
Phone: 901-448-1393